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Melanoma is characterized by a low extracellular pH, which contributes to the development of an aggressive phenotype
characterized by several properties as the switch to an epithelial-to-mesenchymal program, the increase of apoptotic resistance,
and the migratory ability together with the development of drug resistance. Here, we demonstrate that melanoma cells grown
in low pH medium (pH 6.7) for a short (24 hours) or long (at least 3 months) period equally express an anoikis resistance profile.
Anoikis is a form of apoptosis prompted by loss of adhesion, particularly requested by aggressive cancer cells tometastasize. Anoikis
resistance was ascertained in acidic melanoma cells either grown in agarose-coated plates or incubated in rocking conditions. Both
analyses indicate that acidic cells were more able to survive in a nonadherent condition than cells grown in standard pH, an effect
resulting in a more cloning efficiency and migratory ability. Ability to survive during rocking was inhibited using mTOR/NF-kB
inhibitors. Finally, we checked whether characteristics related to the in vitro anoikis resistance acquired by acidic melanoma cells
might be also suitable for in vivo challenge. We injected acidic melanoma cells into blood stream, and then we verify how many
cells survived in blood after 15 min from the injection. Only acidic cells, transient and chronic, survived, whereas melanoma cells
grown in standard pH medium did not. Overall, we have had the opportunity to demonstrate that low extracellular pH represents
an additional mechanism able to promote an anoikis resistance in solid tumors.
1. Introduction
Metastatic disease is a fatal consequence for tumor-bearing
patients and circulating tumor cells (CTCs) are the essential
precondition for metastasis to occur. CTCs leave the primary
tumor, travel through the body’s vasculature, and arrest into
target organ, extravasating and serving as a seed for the
generation of a secondary lesion [1]. In circulation, CTCs
are exposed to several critical conditions, such as survival in
suspension, shear stress, and immune attack; thus survival
can be highly variable disclosing cell populations expressing
a “perfect” circulating phenotype [2].
Among the several aspects characterizing the circulator
phenotype, one of the most critical is anoikis resistance.
Anoikis (i.e., “without a house”) was first described in the
early 1994 by S. Frish and H. Francis [3] and refers to a form
of programmed cell death that occurs when cells detach from
their extracellular matrix (ECM). Normal cells of a tissue die
during this process in view of their stringent requirement of
ECM attachment, whereas certain subpopulations of tumor
cells are able to survive also in total absence or inappropriate
ECM adhesion. Indeed, cancer cells need to survive after
detachment from their primary site and during the travel
through the lymphatic and circulatory systems. This means
that migratory tumor cells have to acquire anoikis resistance
to complete the metastatic cascade; thus resistance to anoikis
might be considered a hallmark of metastatic cancer cells
[4, 5]. Anoikis is controlled by activation of themitochondrial
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apoptotic pathway involving subfamilies of B-cell lymphoma
(Bcl)-2 proteins that lead to the activation of the caspase
enzymes or is induced by the stimulation of death receptors
members of TNF superfamily [6, 7]. Acquisition of anoikis
resistance is obtained through different strategies such as
stimulation of survival signals (PI3K/Akt, MEK, ERK, and
NFkB), inhibition of apoptotic pathways, undergoing EMT,
and/or changing the pattern of integrin expression by adapt-
ing to the metastatic site [7].
Among the different characteristics of tumor microenvi-
ronment we focused on acidosis. Generation of extracellular
acidosis is almost an unavoidable phenomenon during tumor
cell proliferation. Indeed, proliferating cancer cells located
in the proximity of vasculature, where oxygen tension might
be enough to sustain an oxidative phosphorylation, exhibit a
preferred glycolysis pathway (the so-called “Warburg effect”
or aerobic glycolysis), releasing lactate and protons in the
external medium [8–10]. When oxygen tension reduces, the
stabilization of the hypoxia-inducible (HIF)-1𝛼 transcription
factor drives an anaerobic type of glycolysis leading to an
even more pronounced lactate dehydrogenase (LDH)-A-
dependent lactate and proton production. Hypoxic cancer
cells use the monocarboxylate transporter (MCT)-4 and
sodium-proton exporters to discard lactate and protons
[11]. The increased aerobic and anaerobic glycolysis pathway
may be visualized in tumor-bearing patients using 18F-
deoxyglucose positron emission tomography imaging [12].
Overall, most tumor regions experience acidosis (ranging pH
6.7) possibly for a variable period of time, also considering the
reduced movement fluids, due to the low lymphatic vessels
and the high interstitial pressure in the central areas of
tumors [13, 14]. It was demonstrated by our laboratory and
others that decreased extracellular pH (pHe) may contribute
to the promotion of cancer cells aggressiveness via stimu-
lation of increased mutation rate [15], angiogenic [16] and
lymphangiogenic growth factor release [17], metalloprotease-
dependent invasiveness into host tissues [18], and metastatic
potential [19]. All these characteristics are associated with
the acquisition by acidic cancer cells of an epithelial-to-
mesenchymal (EMT) phenotype, endowed with a reduced
rate of proliferation and a high resistance to apoptosis [20].
Both, quiescence and apoptosis resistance of acidic cancer
cells, make these cells a further niche of radio and chemother-
apy resistance and evasion from cytotoxic lymphocytes and
natural killer cells [14]. Most of changes described in acidic
cancer cells are closely associated with NF-kB induction, as
mesenchymal phenotype, apoptosis resistance, and oxidative
phosphorylation [20, 21], whileHIF-1𝛼 is drastically inhibited
by acidosis [22].
All these considerations prompt us to investigate whether
acidosis might also promote in cancer cells an anoikis
resistance profile, as a part of their migratory phenotype.
Here, we demonstrate that transient and chronic acidic-
adapted melanoma cells express an anoikis resistance as a
new additional trait, which may be targeted by mammalian
target of rapamycin (mTOR)/nuclear factor kappa-light-
chain-enhancer of activated B cells (NF-kB) inhibitors.These
findings add new possible mechanisms to control metastatic
spread of melanoma cells.
2. Materials and Methods
2.1. Cell Lines and Culture Conditions. In this study, we used
the melanoma cell line A375M6, isolated in our laboratory
as described in our previous work [23]. In some experiments
we also used the M21 (kindly provided by Dr. Antony
Montgomery, The Scripps Research Institute, La Jolla, CA)
and the WM266-4 (from ATCC) human melanoma cell
lines. Melanoma cells were cultivated in Dulbecco’s Modified
Eagle Medium high glucose (DMEM 4500, EuroClone, MI,
Italy) supplemented with 10% foetal bovine serum (FBS,
Boehringer Mannheim, Germany), at 37∘C in humidified
atmosphere containing 90% air and 10% CO
2
, as described
in our previous work [23].
Cells were harvested from subconfluent cultures by incu-
bation with a trypsin-EDTA solution (EuroClone, MI, Italy)
and propagated every three days. Viability of the cells was
determined by Trypan blue exclusion test. Cultures were
periodically monitored for mycoplasma contamination using
Chen’s fluorochrome test.
2.2. Acidic Treatment. Chemical acidified medium was
obtained by the addition of HCl 1N in DMEM4500 10%
FBS, following the protocol described in [23]; pH value was
monitored by a pHmeter (Orion PHMeter 520A-1) andwhen
pH value was stable (6.7±0.1), acidified medium was added
to cell cultures and the seal cap was tightly closed. pH was
evaluated also at the end of each experiment. For transient
acidosis, cells were grown in acidic medium for 24h. For
chronic acidosis, melanoma cells were cultured in pH 6.7
medium for 3 months, until tumor cells recovered a similar
growth rate as parent cells maintained at pH 7.4. During the
long lasting acidic treatment, no significant death of cells was
found.
2.3. Anoikis Assay. In order to simulate anchorage-
independent growth conditions, we performed two different
tests culturing melanoma cells in dishes coated with agarose
or rocking the cells in tubes.
Culture dishes were coated with 1.5 % agarose (Promega,
San Luis Obispo, California).
5x104 cells were plated in agarose-coated petri dishes in
complete medium and after 5 days colonies were counted.
At the end of the experiments, cells from colonies were
centrifuged and used for western blot analysis, invasion assay,
and Wound Healing Assay.
In rocking test, 5x104 cells were left rocking in tubes
on the Mini Rocker Shaker (Biosan), at room temperature
in Dulbecco’s D-Mem Nutrient mix F12 (DME/F12-HEPES
EuroClone, MI, Italy). In some experiment cells were treated
with esomeprazole (Astra Zeneca, Sweden) and everolimus
(MedChemExpress, Stockholm Sweden) during the rocking
period. After 48h of rocking, cells were centrifuged, counted,
and used for western blot analysis, invasion assay, andWound
Healing Assay.
2.4. Western Blotting Analysis. Cells were washed with ice
cold PBS containing 1 mM Na
4
VO
3
and lysed in 100 𝜇l
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of cell RIPA lysis buffer (Merck Millipore, Vimodrone, MI,
Italy) containing PMSF (Sigma-Aldrich), sodium orthovana-
date (Sigma-Aldrich), and protease inhibitor cocktail (Cal-
biochem). Immunoblot was performed as reported in [21].
Aliquots of supernatants containing equal amounts of protein
in Laemmli buffer were separated on Bolt Bis-Tris Plus
gels 4-12% precast polyacrylamide gels (Life Technologies,
Monza, Italy). Fractionated proteins were transferred from
the gel to a PVDF nitrocellulose membrane using an elec-
troblotting apparatus (Bio-Rad, Segrate,MI, Italy). Blots were
stained with Ponceau red to ensure equal loading and com-
plete transfer of proteins; then they were blocked for 1 hour,
at room temperature, with Odyssey blocking buffer (Dasit
Science, Cornaredo, MI, Italy). Subsequently, the membrane
was probed at 4∘C overnight with primary antibodies diluted
in a solution of 1:1 Odyssey blocking buffer/T-PBS buffer.The
primary antibodies were as follows: rabbit anti-EGFR (1:500
Cell Signaling Technology, Danvers, MA, USA), rabbit anti-
N-Cadherin (1:1000 Biorbyt, Cambridge, UK), mouse anti-
cleaved PARP 1 (1:200 Santa Cruz Biotechnology, Santa Cruz,
California), rabbit anti-p-AKT (Cell Signaling Technology,
Danvers, MA, US), rabbit anti-AKT (1:1000 Cell Signaling
Technology, Danvers, MA, USA), rabbit anti-pERK (1:1000
Cell Signaling Technology, Danvers, MA, USA), rabbit anti-
ERK (1:1000 Cell Signaling Technology, Danvers, MA, USA),
mouse anti-tie1 (1:200 Santa Cruz Biotechnology, Santa Cruz,
California), mouse anti-IKB alpha (1:500 GeneTex, Irvine,
CA USA), and mouse anti-𝛽 actin monoclonal antibody
(1:2000, GeneTex, Irvine, CA,USA). The membrane was
washed in T-PBS buffer, incubated for 1 hour at room tem-
perature with goat anti-rabbit IgGAlexa Fluor 680 antibodies
(Invitrogen,Monza, Italy), and then visualized by anOdyssey
Infrared Imaging System (LI-COR Bioscience). Mouse anti-
𝛽-tubulin monoclonal antibody (Sigma, Saint Louis, MO,
USA) was used to assess equal amount of protein loaded in
each lane.
2.5. Annexin V/PI Flow Cytometer Analysis. Apoptosis was
measured by flow cytometry, using the Annexin V staining
as previously described [23]. Cells incubated in anchorage
independent conditions were collected, washed once with
PBS, resuspended in 100 𝜇L of 1x Annexin-binding buffer
at the concentration of 1 x 106 cells/mL, stained with 5 𝜇L
of Annexin V FITC-conjugated (ImmunoTools, Friesoythe,
Germany) and 1 𝜇L of 100 𝜇g/ml PI working solution, and
incubated at 4∘C in the dark condition for 15 min. Then, 400
𝜇L of 1X Annexin Binding Buffer was added to each sample
and cells were analyzed by flow cytometry (BD-FACS Canto)
to find out the viability (annexin V and PI negative, Q3), early
apoptosis (annexin V positive and PI negative, Q4), or late
apoptosis (annexin V and PI positive, Q2). A minimum of
10000 events were collected.
2.6. Invasion Assay. Invasiveness of A375M6 melanoma
cells incubated in anchorage independent conditions was
determined in vitro on Matrigel (BD Biosciences) precoated
polycarbonate filters, with 8 𝜇m pore size, 6.5 mm diameter,
12.5 𝜇g Matrigel/filter, mounted in Boyden’s chambers, as
previously described [24]. 1,5x105 cells (200 𝜇L) were seeded
in their growth medium in the upper compartment and
incubated for 6 hours at 37∘C in 10% CO
2
in air. In the
lower chamber, complete medium was added as chemoat-
tractant. After incubation, the inserts were removed and
the noninvading cells on the upper surface were wiped off
mechanically with a cotton swab and the membranes were
fixed overnight in ice-cold methanol. Cells on the lower side
of the membranes were then stained using the Diff-Quick kit
(BD Biosciences) and photographs of randomly chosen fields
are taken.
2.7. Wound Healing Assay. Cell migration was evaluated by
an in vitro wound healing assay. The cell layer was wounded
with a sterile 200 ml pipette tip and incubated in 1% FBS
culture medium for 24 hours. The wound was observed after
24 hours and photographed using phase contrast microscopy.
2.8. Cytofluorimetric Assay. Theexpression of integrin recep-
tors 𝛼v𝛽3 and 𝛼v𝛽5 and MHC class I antigens in melanoma
cells was determined by cytofluorimetric analysis (FACScan,
Becton Dickinson, USA). 1x106 melanoma cells were incu-
bated for 30 min at 4∘C with appropriate primary antibody.
Mouse anti-human integrin receptor 𝛼v𝛽3 (clone LM609,
Millipore) and mouse anti-human integrin receptor 𝛼v𝛽5
(sc13588, Sigma), mouse monoclonal AF6-88.5.3 specific
for class I H-2Kb antigen (provided by Dr. S. Gattoni-
Celli, Medical University of South Carolina, USA) (Calorini
1999) or mouse monoclonal HLA-ABC antigen clone W6/32
(DAKO), were used. Cells were washed twice with PBS and
then incubated with FITC-conjugated goat anti-mouse Ig
(Sigma) for 30 min at 4∘C. Cells were washed twice with PBS,
fixed in 2% paraformaldehyde, and stored at 4∘C in the dark
until FACS analysis.
2.9. Blood Stream Survival. Investigation has been con-
ducted in accordance with national guidelines and has been
approved by the ethics committee of the Animal Welfare
Office of the ItalianWorkMinistry and conformed to the legal
mandates and Italian guidelines for the care andmaintenance
of laboratory animals.
Melanoma cells (1x106 cells) adapted to an acidicmedium,
either transiently or chronically, and melanoma cells grown
under standard conditions (pH 7.4) were inoculated intra-
venously into SCID/bg immune deficient mice (Aut Min
401/2015-2019). Mice were anesthetized using Isoflurane
delivered via a precision vaporizer with a nose cone. 15 min
after tumor cells injection, 0,5 ml blood sample was collected
through a cardiac puncture using a preheparinized 25 gauge
x 1󸀠󸀠 needle syringe. Red blood cells were lysed mixing nine
parts sterile H
2
O for 15 sec and then adding one part 10x
PBS. The heterogeneous cell suspensions were distributed in
at least 3 culture dishes. The number of colonies was counted
after 3 weeks of growth in standard conditions and reported
as mean ± SD. Colonies were amplified and pooled together.
2.10. Adhesion to Endothelial Cells. Human umbilical vein
endothelial cells (HUVECs) were grown to confluence in
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24-gelatin precoated well culture plates in complete EGM-
2 Bullet Kit (CC-3162 Lonza) with 10% Fetal Bovine serum
(FBS) (HyClone) and preactivated with rhIL1b (2ng/ml) for
6h. Subconfluent cultures of tumor cells were rinsed with
PBS and exposed to 5𝜇M CellTrace CFSE dye for 15 min
at 37∘C. After incubation cells were incubated in standard
conditions 1h, next tumor cells were detached and seeded
on endothelial cell monolayers at a 1:1 ratio. Cocultures were
incubated at 37∘C for 30 min or 60 min. At designated times
cocultures were rinsed 3 times with serum free medium to
removenonadherent cells and cellswere detached, fixed in 5%
paraformaldehyde, and analyzed by flow cytometry. Human
melanoma cells were identified as CFSE positive cells and
evaluated as percentage of total cell population.
2.11. Statistical Analysis. Densitometric data are expressed as
means ± standard errors of the mean (SEM) depicted by
vertical bars from representative experiment of at least three
independent experiments. Statistical analysis of the data was
performed by Student’s t-test.
3. Results
3.1. Characteristics of Transient and Chronic Acidic-Adapted
Human Melanoma Cells Correlated with an Anoikis-Resistant
Phenotype. To analyze the influence of a reduced pH on
human melanoma cells correlated with an anoikis resistant
phenotype, we exposed A375M6 melanoma cells to a pH
6.7 acidified medium. Since in tumor microenvironment
extracellular acidosis could occur as a short-time insult or
as a prolonged stressed condition, we used 24h acidified
melanoma cells, serving as a model of transient acidosis,
and three months acidified A375M6 to evaluate the effect
of a prolonged acidosis condition (chronic exposure). In
general, chronic exposure in acidosis was considered con-
cluded, when melanoma cells after a period of a reduced
cell proliferation regained their original level of proliferative
activity. Extracellular pH of melanoma frequently ranges
between 6.7 and 6.9; the exposure to an acidic medium did
not change viability of melanoma cells although it stopped
proliferation during the initial phase of treatment.
As we have already demonstrated, acidic cells, both
transient and chronic, express a spindle and dendritic shape
concomitant with an upregulation of N-cadherin and a
downregulation of E-cadherin (Figure 1(a)), characteristics
for an epithelial-to-mesenchymal transition (EMT) program
[20, 23].
As other markers of a possible anoikis resistant phe-
notype, we show (Figure 1(a)) upregulation in acidic
melanoma cells of the epidermal growth factor receptor
(EGFR), an additional prosurvival signaling mediator linked
to ERK and AKT pathways, and of the Tyrosine kinase
with immunoglobulin-like and EGF-like domains (Tie)-
1, a new class of receptor tyrosine kinases specifically
expressed during vascular endothelial cell growth and dif-
ferentiation. EGFR, Tie-1, and Tie-2 receptors on endothelial
cells, once activated, transmit signals through downstream
Raf/mitogen-activated protein kinase (MEK)/ERK pathway
promoting endothelial cell proliferation andmigrationwhich
are essential for angiogenesis induction [25].
Recent studies have shown that it is only after the
cancer cells resist anoikis that they attain the potential to
metastasize [26]. Thus, invasion, a critical step in metastasis,
was investigated. We observed a higher ability of acidic cells
to invade Matrigel filter (see Figure 1(b)), and this invasive
ability was metalloproteinase dependent, as proved by the
inhibition of migration using Ilomastat, an MMP inhibitor
(Figure 1(b)). Further, in our laboratory we found that these
adapted cells were more resistant to proapoptotic agents such
as oxygen peroxide and etoposide, a DNA poison for cancer
cells [20, 23].
An anoikis resistant phenotype is always correlated with
changes in the integrin expression profile [6, 7]. In fact,
Figure 1(c) shows that both transient but in particular chronic
acidic melanoma cells express a more elevated level of 𝛼v𝛽3
and 𝛼v𝛽5 integrins.
3.2. Anoikis Resistant Phenotype in Cells Grown in Agarose-
Coated Dishes. To determine the effect of loss of adhesion
on human melanoma cells grown under standard or low
pH, we cultured cells on agarose-coated dishes. Agarose is
often used as a support to prevent cell adhesion, mimicking
survival, grown in suspension. Acidic and nonacidic cells
were distributed in agarose-coated plates and grown for 5
days in complete medium. At that time, the number of tumor
cell aggregates was evaluated, disclosing the higher ability of
acidic melanoma cells, transient and chronic, to give rise to a
higher number of cell aggregates (Figure 2(a)). In the case of
chronic acidic melanoma cells, aggregates were also charac-
terized by a more elevated diameter (Figure 2(b)). Melanoma
cells collected from the aggregates were investigated for the
level of expression of specific markers and their migration
ability. As reported by NM Forfaria et al., anoikis-resistant
melanoma cells are endowed of highlymigratory and invasive
properties [27].
We found that cells, from both transient and chronic cell
aggregates, express an enhanced level of EGFR in addition to
N-cadherin (Figure 2(c)) aswe have demonstrated in parental
cells [23]. When we tested the cleaved poly ADP-ribose
polymerase 1 (PARP1), as a marker of apoptosis, chronic
acidic melanoma cells recovered from agarose-coated dishes
show a more apoptosis resistance phenotype than transient
acidic cells and control cells. This last finding might support
why aggregates of transient acidic cells are smaller than those
of chronic acidic cells at the end of the experiments. The
evaluation of amoeboid migration by scratch analysis, also
known as wound healing assay (Figure 2(d)), and of the
mesenchymal migration through Matrigel-coated filters of
cells that survived in agarose coated dishes (Figure 2(e)),
revealed that acidic cells recovering from aggregates also
express a better migratory phenotype.
3.3. Anoikis Resistant Phenotype in Rocking Melanoma Cells.
To induce anoikis, cells were also prevented from adhering to
the plastic of cultured flasks by a rocking procedure. Acidic
and nonacidic adapted melanoma cells were suspended in
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Figure 1:An anoikis resistant-like phenotype in acidic melanoma cells. (a) Representative images of western blot for N-cad, EGFR, pAKT/AKT,
pERK/ERK, Tie1, IKB, and 𝛽-actin of A375M6 melanoma cells exposed to standard medium (pH 7.4), to an acidified medium for 24
hours (transient exposure, pH 6.7) or to a reduced pH medium, for approximately three months (chronic exposure, pH 6.7c), and (right)
densitometry graph of protein expression. (b) Representative images (left) of invasiveness of melanoma cells grown in different pH conditions
in the presence or absence of 25𝜇M Ilomastat (a metalloproteinases inhibitor) and quantitative analysis (right) of the number of cells that
migrated through Matrigel. (c) Representative images (left) of flow cytometric analysis of 𝛼v𝛽3 and of 𝛼v𝛽5 integrin expression of A375M6
melanoma cells grown in different pH conditions and (right) quantitative analysis of integrin expression as percentage of increment in Mean
Fluorescent Intensity. Each experiment was conducted in triplicate and data are expressed as mean ± SEM of at least three independent
experiments. ∗ p<0.05.
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Figure 2: Evaluation of the anoikis resistance of acidic melanoma cells grown in agarose. (a) Representative images of acidic and nonacidic
A375M6melanoma cells allowed to growth for other 5 days on agarose-coated dishes and (b) quantification of the number and the dimension
of relative colonies. (c) Representative images (left) of immunoblotting for EGFR, N-cadherin, cleaved PARP1, and 𝛽-tubulin of acidic and
nonacidic A375M6 melanoma cells allowed to growth for other 5 days on agarose-coated dishes and (right) densitometry graph of protein
expression. (d) Representative images of the wound healing assay on acidic and nonacidic A375M6 melanoma cells allowed to growth for
other 5 days on agarose-coated dishes. Images are taken immediately after scratching (t0) and 24 hours later (24h). Percentage indicates
wound closure compared to t0. (e) Representative images (left) of invasiveness of acidic and nonacidic A375M6 melanoma cells allowed to
growth for other 5 days on agarose-coated dishes and quantitative analysis (right) of the number of cells that migrated throughMatrigel. Each
experiment was conducted in triplicate and data are expressed as mean ± SEM of at least three independent experiments. ∗ p<0.05.
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Figure 3:Evaluation of the anoikis resistance of acidicmelanoma cells grown in rocking conditions. (a) Representative images (left) of clonogenic
efficacy in acidic and nonacidic A375M6 melanoma cells after exposure to 24-96 h of rocking condition. After treatment, the cells were
seeded in 100 mm plates (5000 cells/dishes, in triplicate) and incubated for 12–14 days. Quantification (right) of cloning efficiency expressed
as number of colonies. (b) Annexin V/PI flow cytometric analysis of acidic and nonacidic A375M6 melanoma cells after exposure to 48h of
rocking condition; the vital cells were negative for both annexin V and PI staining; the total cell death was the sum of cells positive for annexin
V, PI, or both stainings. (c) Representative images (left) of immunoblotting for EGFR, N-cadherin, cleaved PARP, and 𝛽-tubulin of acidic and
nonacidic A375M6 melanoma cells and after exposure to 48h of rocking condition and (right) densitometry graph of protein expression. (d)
Representative images (left) of the wound healing assay on acidic and nonacidic A375M6 melanoma cells after exposure to 48h of rocking
condition. Images are taken immediately after scratching (t0) and 24 hours later (24 h). Percentage indicates wound closure compared to t0.
(e) Representative images (left) of invasiveness of acidic and nonacidic A375M6 melanoma cells after exposure to 48h of rocking condition
and quantitative analysis (right) of the number of cells that migrated throughMatrigel. Each experiment was conducted in triplicate and data
are expressed as mean ± SEM of at least three independent experiments. ∗ p<0.05.
media free of growth factors and placed in sterile nonadhesive
50 ml tubes that have been fixed on a Mini rocker platform
shaker (20∘ angle) for 24-96 hours, at room temperature at
a speed of 30 cycles/min. Under these conditions, the tubes
were gently rocked and the constant movement of culture
medium ensures a continuous suspension condition also
preventing cell clumping. Cells which have been cultured
under rocking were collected and their cloning efficiency
was evaluated on standard culture condition. After 2 weeks
of growth, as reported in Figure 3(a), we found that at the
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Figure 4: Evaluation of anoikis resistance of WM266-4 and M21 melanoma cells. (a) Representative images of clonogenic efficacy of acidic
and nonacidicWM266-4 andM21melanoma cells after exposure to 72h of rocking condition. After treatment, the cells were seeded in 100mm
plates (5000 cells/dishes, in triplicate) and incubated for 15 days. (b) Quantification of cloning efficiency expressed as number of colonies. (c)
AnnexinV/PI flow cytometric analysis of acidic and nonacidicWM266-4 andM21melanoma cells after exposure to 48h of rocking condition.
Each experiment was conducted in triplicate and data are expressed as mean ± SEM of at least three independent experiments. ∗ p<0.05.
48th hour of rocking a slight difference in the clonogenic
ability between acidic cells and standard cells starts to
be appreciated. Indeed, measurement of level of apoptosis,
determined by the annexin method, indicates a significantly
higher number of death cells in controlmelanoma cells (more
than 55%) than in acidic cells (5-25%) after 48 hours of
rocking condition (Figure 3(b)). In addition, acidic cells,
either transient or chronic, were able to express a high
capacity to give rise to numerous cell clones, while rocked
melanoma cells grown in standard pH were unsuccessful
(Figure 3(a)). These data indicate that acidic melanoma cells
express a more resistant anoikis phenotype. In order to
link anoikis resistance to specific markers and migratory
ability, we collected 48-hour-rocking melanoma cells for the
following experiments. Anoikis resistant cells derived from
acidic melanoma cells conserved a slightly higher level of
N-cadherin expression, consistent with a more EMT profile
(Figure 3(c)). Associated with EMT profile, these latter
melanoma cells are characterized by a faster ability to close
the wounds (Figure 3(d)) as a significant higher ability to
cross Matrigel-coated filters (Figure 3(e)). Regarding apop-
totic escaping and cell survival, melanoma cells collected
from acidic, transient and chronic, clones show a clear
reduction of cleaved PARP1 and an enhanced expression of
EGFR (Figure 3(c)). To verify whether the acidosis-induced
anoikis-resistant phenotype observed in A375M6 cells is an
aspect even of other melanoma cell lines grown in acidic
microenvironment, we also undertook WM266-4 and M21
melanoma cells to rocking condition for 72h. As shown in
Figures 4(a) and 4(b), both acidic WM266-4 (in particular
chronic acidic cells) and M21 cells expressed a higher ability
to give rise to cell colonies. Moreover, the determination of
the level of apoptosis indicates a significantly lower number
of death cells in acidic cells than in control cells at the 48th
hour of rocking condition (Figure 4(c)).
Considering our previous experience on the ability of
esomeprazole, a proton pump inhibitor that requires acidosis
for its activation, to prevent NF-𝜅B activation [17, 28], we
rocked for 48 hours acidic and nonacidic melanoma cells
in the presence of esomeprazole. Figure 5(a) shows the
ability of esomeprazole to abrogate cloning efficiency of acidic
and nonacidic anoikis resistant melanoma cells. In addition,
considering the fact that low pH microenvironment pro-
motes in melanoma cells a vemurafenib resistant phenotype,
which could be targeted using an mTOR inhibitor, such as
everolimus [23], we decided to test sensitivity of anoikis
resistant acidic and nonacidic melanoma cells to everolimus.
Indeed, as shown in Figure 5(b), everolimus is effective in
abrogating cloning efficiency of acidicmelanoma cells rocked
for 48 hours and also of melanoma cells grown in standard
pH.
Overall, a low pH adaptation, both transient and chronic,
exerts an anoikis resistant phenotype in melanoma cells
endowed with increased proliferative signals, reduced apop-
tosis markers, and an esomeprazole/everolimus sensitivity.
3.4. In vivo Evaluation of Anoikis-Resistant Phenotype. We
have next investigated the ability of melanoma cells to
survive in the blood stream. To test this phenomenon, an
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Figure 5: Cloning efficiency of rocking melanoma cells exposed to esomeprazole or everolimus. (a) Representative images (left) of clonogenic
efficacy of acidic and nonacidic A375M6 melanoma cells after exposure to 48h of rocking condition in the presence or in the absence of 100
𝜇M esomeprazole (a proton-pump inhibitor). After treatment, the cells were seeded in 10 mm plates (5000 cells/dishes, in triplicate) and
incubated for 15 days. Quantification (right) of cloning efficiency expressed as number of colonies (untreated, UT). (b) Representative images
(left) of clonogenic efficacy of acidic and nonacidic A375M6 melanoma cells after exposure to 48h of rocking condition in the presence or
in the absence of 2 𝜇M everolimus (an inhibitor of mTOR). After treatment, the cells were seeded in 100 mm plates (5000 cells/dishes, in
triplicate) and incubated for 15 days. Quantification (right) of cloning efficiency expressed as number of colonies (untreated, UT). Data are
expressed as mean ± SEM of at least three independent experiments. ∗ p<0.05.
equal number of melanoma cells (1x106 cells) adapted to
an acidic medium, either transiently or chronically, and
melanoma cells grown under standard conditions (pH 7.4)
were inoculated intravenously into immune deficient mice.
Mice were sacrificed 15 min after tumor cells injection to
collect, by a cardiac puncture, 0.5 ml of blood. A period of 15
min represents a time of observation long enough to evaluate
resistance of tumor cells in blood stream and, at same time,
short enough to prevent trapping of melanoma cells in the
capillary bed of the lungs [29]. Blood of injected mice was
treated with a hypotonicmedium to eliminate red blood cells;
thereafter the heterogeneous cell suspension was distributed
in culture dishes. At the 21st day of growth, we counted
number of colonies and, as we report in Figure 6(a), control
cells give no colonies, whereas both types of acidic melanoma
cells reach a range of 40-50 colonies. To validate these
experiments, melanoma cells were collected from colonies
and tested, by immunofluorescence, for level of expression
of murine and human Major Histocompatibility Complex
(MHC) class I antigens. Figure 6(b) shows that cells collected
from the clones express human MHC class I antigens (A, B,
and C alleles), but not murine H2-Kb antigen. Thus, acidic
cells express an enhanced ability to survive in blood stream.A
stringent request for perfect “circulating tumor cells” (CTC)
is the capacity to adhere to endothelial cells, a step before
extravasation and secondary organ colonization. Therefore,
we compared the adhesive properties of acidic cells with
that of control cells. Labeled melanoma cells were added to
a monolayer of human endothelial cells and incubated for
30-60 min at 37∘C. Then, nonadherent cells were washed
out using a phosphate buffer, and both the endothelial
cells and the corresponding attached melanoma cells were
collected by trypsinization. Flow cytometry analyses reported
in Figure 6(c) reveal that chronic acidic melanoma cells
show an enhanced aptitude to stick to endothelial cells.
This finding deserves further investigations in order to
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Figure 6: In vivo evaluation of anoikis resistance of acidic melanoma cells. (a) Emerging colonies derived from blood sample obtained from
mice (n=3) i.v. injected with acidic and nonacidic A375M6 melanoma cells; colonies with over 20 cells were counted. (b) Representative
images of flow cytometer analysis of HLA-ABC or H2Kb antigen expression in pooled cell population that recovered from blood samples
after 21 days. (c) Evaluation of adhesiveness of acidic and nonacidic A375M6 melanoma cells toward activated endothelial cells at 30 and 60
min through flow cytometer analysis of acidic and nonacidic CSFE-positive A375M6 melanoma cells and activated endothelial cells (CSFE-
negative) cocultures. Images are representative of experiments performed in triplicate; data are expressed as mean ± SEM of at least three
independent experiments. ∗ p<0.05.
clarify whether acidic melanoma cells are also endowed in
metastatic niche formation, the final ability of a “perfect”
CTC.
4. Discussion
Clarifying the mechanisms regulating the acquisition of
a resistant anoikis program is necessary to develop new
strategies to combat metastatic dissemination. Several strate-
gic pathways may confer anoikis resistance to cancer cells,
including activation of prosurvival pathways (e.g., PI3-K,
MEK/ERK, and NF-kB), change in integrin expression,
secretion of reactive oxygen species (ROS), and acquisition
of an EMT profile [6, 7].
Here, we show for the first time that an acidic pH
medium, related to Warburg effect and/or anaerobic glycol-
ysis of tumor cells, promotes in human melanoma cells an
anoikis resistant phenotype, a further trait of malignancy.
Anoikis resistance is useful to survive in blood stream and in
the various circumstances in which melanoma cells endowed
with an aggressive phenotype need to detach from extra-
cellular matrix (ECM) and survive in suspension. Indeed,
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melanocytes are kept in their tissue compartment through
integrin/ECM interactions, but the underlying dermis is rich
in collagen, failing to support melanocyte adhesion and
survival, as they do not express suitable integrins. However,
during melanoma dermis invasion, the upregulation of 𝛼v𝛽3
integrin allows them to receive antiapoptotic signals to
survive anoikis [30]. Our model of acidic cells was repre-
sented by transient (24 hours) and chronic (three months)-
adapted murine sarcoma viral oncogene homolog B (BRAF)
melanoma cells to mimic short and long exposure of cancer
cells to low pH. pH 6.7 is the level of acidity more frequently
observed in spontaneous human melanoma. During our
investigations on acidity and melanoma progression we
collected several findings suggesting that acidic melanoma
cells could be a very good candidate for also expressing an
anoikis resistance, such as a switch to anEMTprofile (highN-
Cadherin, low E-Cadherin), high MMP-dependent invasive
ability, apoptotic resistance, and an AKT/mTOR privileged
pathway [20, 23]. Indeed many recent studies show that EMT
increases metastatic potential of cancer cells by mediating
anoikis resistance [31, 32]; particularly it was demonstrated
that the depletion of E-cadherin promotes mammary cell
survival following loss of cell adhesion to the ECM [33], and
N-cadherin expression protects melanoma cells from anoikis
[34, 35] and confers apoptosis resistance to esophageal
carcinoma cells [36]. In addition to an increased expression
of N-Cadherin, acidic cells showed an upregulation of 𝛼v𝛽3
and 𝛼v𝛽5 integrins and ERK and AKT activation. Indeed, to
alter the integrin repertoire in response to selective microen-
vironmental pressures is considered another strategy to avoid
anoikis [37] and a key player in integrin-mediated signal
transduction leading to anoikis protection is ERK, whereas
Akt is an essential element of cell survival signaling as
integrin-, growth factor-, and cell–cell anchorage-mediated
signals converge to its activation to grant survival of cells [38].
Another important observation obtained previously in
our laboratory was that when acidic melanoma cells were
injected intravenously with nonacidic cells, they improved
the capability of cells grown at standard pH to give rise to
lung metastasis [20]; this fact suggested that the nonacidic
melanoma subpopulation was able to promote the devel-
opment of lung colonies and that the prometastatic role of
acidic cells could be the protection of nonacidic cells in
blood stream and/or the ability to favor their attachment
on lung endothelial cells and the following lodgment into
the lung parenchyma. Along these suggestions, we validated
that acidic melanoma cells are endowed with an anoikis
resistant phenotype growing both acidic and control cells in
nonadherence conditions, for example, grown on agarose-
coated dishes, under rocking, and finally exposing cancer
cells to the in vivo blood stream.Wewere able to demonstrate
that acidic melanoma cells give a more elevated number
of cell aggregates when they were plated on agarose-coated
dishes. At the same time, acidic melanoma cells exposed to
a continuous rocking expressed a better clonogenic ability
than control cells, for example, the capacity to develop a
very high number of clones. Thus, the acquisition of a low
pH phenotype, after transient but also chronic exposure
to an acidic medium, implies the anoikis resistance. It is
possible that acidity generates an anoikis resistant profile by
modulating EMTprogram, expression of adhesionmolecules
(specific 𝛼v integrins), growth factor receptor (EGFR), and
specific transcription factor pathways (pAKT/mTOR, and
NF-kB). Thus, a molecular signature elicited by a reduced
extracellular pH is adequate to confer the ability to survive
without attachment to the ECM.
An important distinguishing factor of anoikis resistant
acidic melanoma cells was the upregulation of EGFR and
AKT pathway. Epidermal growth factor and its receptor can
lead to increased PI3-K signaling.This signaling has an effect
on downstream substrate AKT and its phosphorylation. This
activates themTOR (Target of Rapamycin) which contributes
to the development of an anoikis resistance. Boisvert-Adamo
K and Aplin AE showed that two major survival pathways
work in BRAF melanoma cells to provide a protection from
anoikis: the B-RAF-MEK and the PI-3 kinase-AKT signaling
[39]. Indeed, A375-M6 melanoma cells are BRAF mutated
(V600E) andwhen they are adapted to an acidicmedium they
acquire an enhanced activation of PI-3 kinase-AKT pathway
crucial for vemurafenib resistance development, as we have
previously demonstrated [23]. Indeed, we have demonstrated
that an mTOR/NF-kB inhibitor drives a significant killing
of acidic anoikis resistant melanoma cells. Also, the subpop-
ulation of nonacidic anoikis resistant cells was sensitive to
mTOR/NF-kB inhibition.
PI3 kinase-AKT and ERK activation is reported to
characterize melanoma cells upon anchorage independency
and syndecan 2 (SDC2) increased expression. SDC2 is also
associated with a higher expression ofmigratory andmelanin
synthesis [40].
UsingRNA interference, Boisvert-AdamoK. et al. showed
that depletion of myeloid cell leukemia (Mcl)-1 renders
mutant B-RAF melanoma cells sensitive to anoikis. By
contrast, minor effects were observed following depletion
of either Bcl-2 or Bcl-XL. Mcl-1 expression is enhanced in
melanoma cells compared with melanocytes and upregulated
by the B-RAF-MEK-extracellular signal-regulated kinase
pathway through the control of Mcl-1 protein turnover [41].
Among the othermarkers, the signal transducer and activator
of transcription (STAT)3, that is associated with anoikis
resistance in melanoma cells, as Fofaria and Srivastava
demonstrated [27], was unmodified by low pH exposure
(data not shown).
Wound healing and Boyden’s chamber assays suggested
that the acidic anoikis-resistant melanoma cells express
an enhanced motility and invasiveness through Matrigel,
according to the recent observation that anoikis resistant cells
show increased cell migration and invasion [42]. Finally, the
ability of acidic melanoma cells to survive in blood stream is
particularly interesting because this finding not only sustains
in vivo the anoikis profile of these cells but also predicts the
possible involvement of acidic-adaptedmelanoma cells in the
following steps of metastatic cascade, such as endothelial cell
adhesion, extravasation, and lodgment into the secondary
organ.Wemay consider these final steps as candidates for our
next research effort.
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5. Conclusions
In summary, our findings show that a low pHmicroenviron-
ment is crucial in conferring to melanoma cells an anoikis
resistant trait. This evidence underscores the importance of
targeting low pH of melanoma, likely combining mTOR/NF-
kB inhibitors.
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